Virtsankarkailu (naiset) näytönastekatsausten kirjallisuusviitteet

Kirjallisuutta

1. Aguiar LB, Politano CA, Costa-Paiva L, ym. Efficacy of Fractional CO(2) Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial. Lasers Surg Med 2020;52(8):713-720 «PMID: 31990089»PubMed
2. Alexander JW, Karjalainen P, Ow LL, ym. CO(2) surgical laser for treatment of stress urinary incontinence in women: a randomized controlled trial. Am J Obstet Gynecol 2022;227(3):473.e1-473.e12 «PMID: 35662546»PubMed
3. Ananda IGYP, Surya RNH, Surya PA, ym. Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis. Urol Ann 2025;17(1):2-8 «PMID: 40051990»PubMed
4. Athanasiou S, Pitsouni E, Grigoriadis T, ym. Mirabegron in female patients with overactive bladder syndrome: What's new? A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2020;251():73-82 «PMID: 32480182»PubMed
5. Chen YY, Su TH, Lau HH. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials. Int Urogynecol J 2021;32(1):17-25 «PMID: 32564121»PubMed
6. Cody JD, Jacobs ML, Richardson K, ym. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2012;10(10):CD001405 «PMID: 23076892»PubMed
7. Dey A, Georgiadis G, Umezurike J, ym. Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome-A Systematic Review. Eur Urol Focus 2025;11(2):323-336 «PMID: 39343691»PubMed
8. Drake MJ, Nitti VW, Ginsberg DA, ym. Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis. BJU Int 2017;120(5):611-622 «PMID: 28670786»PubMed
9. Dueñas-Garcia OF, Sullivan G, Hall CD, ym. Pharmacological Agents to Decrease New Episodes of Recurrent Lower Urinary Tract Infections in Postmenopausal Women. A Systematic Review. Female Pelvic Med Reconstr Surg 2016;22(2):63-9 «PMID: 26825411»PubMed
10. Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2018;10(10):CD005654 «PMID: 30288727»PubMed
11. Farag F, Sakalis VI, Arteaga SM, ym. What Are the Short-term Benefits and Potential Harms of Therapeutic Modalities for the Management of Overactive Bladder Syndrome in Women? A Review of Evidence Under the Auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel. Eur Urol 2023;84(3):302-312 «PMID: 37331921»PubMed
12. Ford AA, Rogerson L, Cody JD, ym. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 2017;7(7):CD006375 «PMID: 28756647»PubMed
13. Funada S, Yoshioka T, Luo Y, ym. Bladder training for treating overactive bladder in adults. Cochrane Database Syst Rev 2023;10(10):CD013571 «PMID: 37811598»PubMed
14. Hargreaves E, Baker K, Barry G, ym. Acupuncture for treating overactive bladder in adults. Cochrane Database Syst Rev 2022;9(9):CD013519 «PMID: 36148895»PubMed
15. Herbison P, McKenzie JE. Which anticholinergic is best for people with overactive bladders? A network meta-analysis. Neurourol Urodyn 2019;38(2):525-534 «PMID: 30575999»PubMed
16. Kennelly M, Wielage R, Shortino D, ym. Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis. Drugs Context 2022;11(): «PMID: 36303599»PubMed
17. Klein J, Stoddard M, Rardin C, ym. The Role of Pessaries in the Treatment of Women With Stress Urinary Incontinence: A Systematic Review and Meta-Analysis. Female Pelvic Med Reconstr Surg 2022;28(6):e171-e178 «PMID: 35420550»PubMed
18. Labrie J, Berghmans BL, Fischer K, ym. Surgery versus physiotherapy for stress urinary incontinence. N Engl J Med 2013;369(12):1124-33 «PMID: 24047061»PubMed
19. Lange S, Lange R, Tabibi E, ym. Comparison of Vaginal Pessaries to Standard Care or Pelvic Floor Muscle Training for Treating Postpartum Urinary Incontinence: a Pragmatic Randomized Controlled Trial. Geburtshilfe Frauenheilkd 2024;84(3):246-255 «PMID: 38455997»PubMed
20. Lauterbach R, Aharoni S, Justman N, ym. The efficacy and safety of a single maintenance laser treatment for stress urinary incontinence: a double-blinded randomized controlled trial. Int Urogynecol J 2022;33(12):3499-3504 «PMID: 35195738»PubMed
21. Mariappan P, Ballantyne Z, N'Dow JM, ym. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database Syst Rev 2005;2005(3):CD004742 «PMID: 16034945»PubMed
22. Maund E, Guski LS, Gøtzsche PC. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. CMAJ 2017;189(5):E194-E203 «PMID: 28246265»PubMed
23. Nitti VW, Kohan A, McCammon K, ym. Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis. Neurourol Urodyn 2024;43(8):1765-1775 «PMID: 38973548»PubMed
24. Perrotta C, Aznar M, Mejia R, ym. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008;(2):CD005131 «PMID: 18425910»PubMed
25. Peters KM, Carrico DJ, Perez-Marrero RA, ym. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol 2010;183(4):1438-43 «PMID: 20171677»PubMed
26. Phelan S, Kanaya AM, Subak LL, ym. Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J Urol 2012;187(3):939-44 «PMID: 22264468»PubMed
27. Schreiner L, Nygaard CC, Dos Santos TG, ym. Transcutaneous tibial nerve stimulation to treat urgency urinary incontinence in older women: 12-month follow-up of a randomized controlled trial. Int Urogynecol J 2021;32(3):687-693 «PMID: 33057739»PubMed
28. Seki AS, Bianchi-Ferraro AMHM, Fonseca ESM, ym. CO(2) Laser and radiofrequency compared to a sham control group in treatment of stress urinary incontinence (LARF study arm 3). A randomized controlled trial. Int Urogynecol J 2022;33(12):3535-3542 «PMID: 35254473»PubMed
29. Shi H, Chen H, Zhang Y, ym. The efficacy and safety of Vibegron in treating overactive bladder: A systematic review and pooled analysis of randomized controlled trials. Neurourol Urodyn 2020;39(5):1255-1263 «PMID: 32421908»PubMed
30. Siddiqui F, Petersen JJ, Juul S, ym. Beneficial and harmful effects of duloxetine versus placebo, 'active placebo' or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ Open 2025;15(2):e082853 «PMID: 39920066»PubMed
31. Simunić V, Banović I, Ciglar S, ym. Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet 2003;82(2):187-97 «PMID: 12873780»PubMed
32. Stoniute A, Madhuvrata P, Still M, ym. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. Cochrane Database Syst Rev 2023;5(5):CD003781 «PMID: 37160401»PubMed
33. Subak LL, Wing R, West DS, ym. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009;360(5):481-90 «PMID: 19179316»PubMed
34. Teixeira Alve A, Azevedo Garcia P, Henriques Jácomo R, ym. Effectiveness of transcutaneous tibial nerve stimulation at two different thresholds for overactive bladder symptoms in older women: a randomized controlled clinical trial. Maturitas 2020;135():40-46 «PMID: 32252963»PubMed
35. Visco AG, Brubaker L, Richter HE, ym. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med 2012;367(19):1803-13 «PMID: 23036134»PubMed
36. Woodley SJ, Lawrenson P, Boyle R, ym. Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev 2020;5(5):CD007471 «PMID: 32378735»PubMed
37. Wu X, Zheng X, Yi X, ym. Electromyographic Biofeedback for Stress Urinary Incontinence or Pelvic Floor Dysfunction in Women: A Systematic Review and Meta-Analysis. Adv Ther 2021;38(8):4163-4177 «PMID: 34176082»PubMed
38. Yang N, Ge X, Ye J, ym. Efficacy of acupuncture for urinary incontinence in middle-aged and elderly women: A systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 2021;257():138-143 «PMID: 33419589»PubMed